Please assess the completion status of the following clinical trial:

Trial Title: Immediate Effect of Ultrasound Therapy on Bilateral Masseter Myalgia: Randomized Single Blinded Investigational Trial

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 4.0

Eligibility Criteria:
Inclusion Criteria:~* Adult females who have bilateral myalgia based on Diagnostic Criteria for TMD (DC-TMD) criteria and current pain intensity (≥4 out of 10, where 0 is no pain and 10 is the worst pain ever) on both sides.~Exclusion Criteria:~* Those who have a history or were diagnosed with systemic musculoskeletal disorders or rheumatologic diseases (e.g. fibromyalgia, muscular atrophy).~* Certain conditions such as neoplasms or fractures.~* Neuropathies or neurological disorders.~* Participants who are currently taking muscle relaxants or analgesics.~* Those who have undergone any form of physical therapy within the last 60 days.

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- A: 0.4 Watts/Sq cm 50% Duty cycle (Type: EXPERIMENTAL): 0.4 Watts/Sq cm 50% Duty cycle Therapeutic ultrasound (Ultrasound Sonicator 740) used on masseter muscle, 1 (MegaHertz) MHz, 5 minutes
- B: 0.4 Watts/Sq cm 100% Duty cycle (Type: EXPERIMENTAL): 0.4 Watts/Sq cm 100% Duty cycle Therapeutic ultrasound (Ultrasound Sonicator 740) used on masseter muscle, 1 MHz, 5 minutes
- C: 0.8 Watts/Sq cm 50% Duty cycle (Type: EXPERIMENTAL): 0.8 Watts/Sq cm 50% Duty cycle Therapeutic ultrasound (Ultrasound Sonicator 740) used on masseter muscle, 1 MHz, 5 minutes
- D: 0.8 Watts/Sq cm 100% Duty cycle (Type: EXPERIMENTAL): 0.8 Watts/Sq cm 100% Duty cycle Therapeutic ultrasound (Ultrasound Sonicator 740) used on masseter muscle, 1 MHz, 5 minutes

Based on this trial design, predict the completion outcome and termination type (if applicable).